Distinct CD3 + CD14 + T Cell-Monocytes are dynamic complexes that harbor HIV and are increased with glucose intolerance.
Distinct CD3 + CD14 + T Cell-Monocytes are dynamic complexes that harbor HIV and are increased with glucose intolerance.
复制标题
独特的 CD3 CD14 T 细胞-单核细胞是携带 HIV 的动态复合物,并随着葡萄糖不耐受而增加。
DOI:
10.1101/2023.04.24.538020
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Gangula,Ram
中科院分区:
文献类型:
--
作者:
Wanjalla,CelestineN;Simmons,Joshua;Oakes,Jared;Zhang,Xiuqi;Nochowicz,Cindy;Priest,Stephen;Bailin,SamuelS;Warren,ChristopherM;Mashayekhi,Mona;Beasley,HeatherK;Wang,Jian;Meenderink,Leslie;Sheng,Quanhu;Stolze,Joey;Gangula,Ram
An increased risk of cardiometabolic disease accompanies persistent systemic inflammation. Yet, the innate and adaptive immune system features in persons who develop these conditions remain poorly defined. Doublets, or cell-cell complexes, are routinely eliminated from flow cytometric and other immune phenotyping analyses, which limits our understanding of their relationship to disease states. Using well-characterized clinical cohorts, including participants with controlled HIV as a model for chronic inflammation and increased immune cell interactions, we show that circulating CD14+ monocytes complexed to CD3+ T cells are dynamic, biologically relevant, and increased in individuals with diabetes after adjusting for confounding factors. The complexes form functional immune synapses with increased expression of proinflammatory cytokines and greater glucose utilization. Furthermore, in persons with HIV, the CD3+T-cell: CD14+monocyte complexes had more HIV copies compared to matched CD14+ monocytes or CD4+ T cells alone. Our results demonstrate that circulating CD3+T-cell:CD14+monocyte pairs represent dynamic cellular interactions that may contribute to inflammation and cardiometabolic disease pathogenesis and may originate or be maintained, in part, by chronic viral infections. These findings provide a foundation for future studies investigating mechanisms linking T cellmonocyte cell-cell complexes to developing immune-mediated diseases, including HIV and diabetes.